Just to throw my two cents in...
24% reduction in death
Just to throw my two cents in...
24% reduction in death sure seems like a good thing, a very good thing.
Getting out of the hospital 6 days sooner also seems like a very good thing.
I don't believe there has been anything else close to those results, and yet there are approved drugs for Covid.
Not being in the medical field or otherwise have the experience of many on this board, I'm frustrated and even confused why a p-value can be more important than the 2 results above. And I'm dismayed that the FDA may not approve these results because of a p-value.
BUT, do we KNOW they will not be granting an EUA while additional tests are being completed? As I've read way too many posts over this weekend, I don't believe I have heard knowledgeable statement that an EUA will not be granted at this time. I know Nader said it was against the law for one to be granted if p not <.05...and I cannot believe that is a fact.(That was a horrible interview with Been. CytoDyn needs a better spokesperson, IMHO.) But it appears to me that the FDA can do whatever it pleases for their own purposes. I have not given in to accepting that an EUA is not forthcoming, and think it could come from our FDA as well as 1,2 or 3 others.
Obviously with all the diverse opinions on this board over the weekend, anything could happen tomorrow to the stock price, and clearly there is no way of knowing yet. I agree worst case is we do some more tests and wait another 2-3 months for a confirmation and then we have money in the bank. IF we need to raise some money in the mean time it would be a small amount and nothing significant for concerns of dilution. We'll all be fine in the long run, yes it's hard to keep hearing that, but it is true. These results at least prove that for Covid...and beyond.
To The Moon Alice
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Pushing the Boundaries with Cloud Sync Another day, another software upgrade. MiniTool ShadowMaker has jumped to version 5.0, throwing in a new Cloud Sync feature for Google Drive and OneDrive. Now, you might not be jumping out of your chair with excitement just yet, but hear me out. For those who fiddle with Windows backup and file sync often enough to owe Microsoft a...
Continue Reading
A Milestone and a Homecoming Who would've thought? Cole Haan, the American staple that seems to draw from an old-world charm and modern flair, is making waves again. They've just hit their 600th store mark—a number not to scoff at, especially when retail's felt the squeeze lately. But it’s not just about another number. It’s about a return, a resounding "we still...
Continue Reading
Riding the Wave of Sustainable Coatings Who'd have thought we'd be chatting about wood coatings making such a splash? Turns out, this unsung hero of the materials world is gearing up for some serious growth, with the market projected to hit a crisp $33.34 billion by 2032. That's a decent jump from where it stands today, and it's all thanks to the shift towards...
Continue Reading
Making Waves with Cutting-Edge Drug Platforms Ah, how time flies in the biotech universe. Here we are, with ImmunoForge prepping to flaunt its high-tech gear at the big show in Cologne: BIO-Europe 2026. The company's aiming to gauge attention with its flashy ELP and LMT platforms, primed and ready for strategic partnerships. ELP: Revolutionizing Drug Delivery You've got...
Continue Reading
Addressing Stubborn Material Flow Blockages You've got a silo, but the darn thing just won't empty smoothly. It's a real head-scratcher for anyone in material handling. Everyone from cement mixers to cereal processors has faced this dilemma. Zach Janosky, an expert from Global Manufacturing, sheds some light on why materials get stuck and how to keep them moving. Why...
Continue Reading
Crunch Time for Post Holdings: Earnings Insight Well folks, pull out your calendars because November 20 is shaping up to be a big day for those tracking Post Holdings, Inc. (NYSE:POST). If you're in the game, this upcoming conference call is your prime chance to get the scoop on how the numbers stack up for Q4 and what's brewing for fiscal year 2027. This isn't some...
Continue Reading
Bracing for the Delisting Impact Well, isn't that a familiar tune? Lunai Bioworks Inc., ticking with the symbol NASDAQ:LNAI, is pulling the plug on its Nasdaq listing faster than a kid yanking out a loose tooth. On October 21, 2026, the company's board decided it's cheaper and simpler to step off the dance floor than keep paying for a spot when the music's stopped....
Continue Reading
Community Heritage's Bold Move: A Stock Repurchase Well, here's a curveball in the financial game: Community Heritage Financial, Inc., the brain behind Middletown Valley Bank, recently threw its hat into the stock repurchase ring. This Maryland-rooted outfit announced on October 22, 2026, that its Board of Directors approved a program permitting the buyback of up to...
Continue Reading
Rethinking the Auditing Game Well, what do you know? Sivers Semiconductors just gave the boot to Deloitte AB. Looks like they're rolling out the welcome mat for Ernst & Young AB to scrutinize their books instead. The move, coming hot from the Extraordinary General Meeting, shows they're not messing around with their financial oversight. Maybe it's a bid for fresh...
Continue Reading
Home2 Suites East Hanover Welcomes Holiday Travelers Picture this: a cozy spot near Whippany Station, where those catching a ride on THE POLAR EXPRESS™ could enjoy a perfect holiday stay. Welcome to Home2 Suites by Hilton East Hanover, a spot that's rolling out the welcome mat this season for families trotting over to Morris County, New Jersey. A Family-Friendly Escape...
Continue Reading
Top 5 Most Recently Viewed Articles
Ryan Specialty Acquires Velocity Risk Underwriters Ryan Specialty (NYSE: RYAN), a prominent force in the international specialty insurance arena, has recently made headlines by signing an agreement to acquire Velocity Risk Underwriters, LLC. This acquisition represents a significant expansion of Ryan Specialty's offerings, particularly in the realm of first-party...
Continue Reading
Oncotelic Therapeutics: Redefining Cancer Care Oncotelic Therapeutics Inc. (OTCQB: OTLC) is emerging as a key player in the biopharmaceutical industry, focusing on innovative treatments for cancer and rare diseases. This clinical-stage company is at the forefront of developing therapeutic solutions that meet significant medical needs. Aggressive cancers such as...
Continue Reading
Exciting New Ventures for Spin Master The entertainment landscape is buzzing with the news that Spin Master Corp. has taken a bold step by greenlighting its first original animated film. This marks a significant milestone for the company, known for creating beloved children's television series. Directed by the talented David Soren, this project aims to broaden Spin...
Continue Reading
Let's cut through the chatter: Drayton Aerospace is not just coasting; they're revamping their MRO (Maintenance, Repair, and Overhaul) game with a fresh partnership that’s set to shake things up. They’re bringing IFS into the mix, specifically leveraging their EmpowerMX software. This isn’t some half-baked plan—it's about optimizing operations that directly impact...
Continue Reading
Understanding McDonald's Stock Performance and P/E Ratio Currently, McDonald's Inc. shows a stock trading price of $304.19, reflecting a minor increase of 0.05%. Over the past month, the stock has seen a rise of 2.58%. In the last year, the stock has surged by 21.71%. This robust performance encourages long-term investors, yet many are keenly analyzing the...
Continue Reading